School of Biological, Earth and Environmental Sciences, University of New South Wales, Sydney, 2052, Australia.
J Comp Physiol B. 2021 Jul;191(4):777-791. doi: 10.1007/s00360-021-01367-9. Epub 2021 Apr 20.
Mechanisms of saliva formation by wombat parotid glands were investigated in anaesthetized wombats at two levels of cholinergically-stimulated flow viz. mid-range (30-40% maximum flow) and maximum flow using ion-transport and carbonic-anhydrase inhibitors. Bumetanide (0.005-0.1 mmol l carotid plasma) progressively reduced mid-range flow by 52 ± 3.4% (mean ± SEM). Concurrently, saliva [Cl] decreased, [Na] and [HCO] increased but HCO excretion was unaltered. Salivary flow during high-rate cholinergic stimulation was 31 ± 1.1% of the pre-bumetanide maximum. During mid-range stimulation, SITS (0.075 mmol l) was without effect whereas 0.75 mmol l stimulated transient increases in fluid output. The higher SITS concentration caused no alterations to flow or electrolyte concentrations during maximal stimulation. Carotid plasma [amiloride] (0.05 mmol l) caused immediate falls in flow rate of 20-30% followed by progressive recovery over 25 min to levels above pre-amiloride flow rates despite plasma [amiloride] increasing tenfold. Concurrently, salivary [Na] and [Cl] rose to equal plasma concentrations and [K] fell by 50% indicating blockade of acinar Na/H exchangers and luminal Na channels in the ducts. Increased salivary osmolarity caused the flow recovery. Saliva flow during maximum cholinergic stimulation was reduced by 38-46%. The depression of flow was interpreted as resulting from competition between amiloride and acetylcholine for access to the muscarinic receptors. Plasma [acetazolamide] (0.35-2.5 mmol l) did not alter saliva outflow during mid-range or maximum flow regimes whereas salivary [Cl] increased and [HCO] decreased consistent with reduced anion exchange resulting from inhibition of carbonic anhydrase. Combined with bumetanide, acetazolamide (1.5 mmol l) reduced flow by an additional 18-22% relative to bumetanide alone thereby demonstrating that acinar HCO synthesis supported a limited proportion of saliva formation and that some HCO secretion was independent of carbonic anhydrase activity.
在麻醉袋熊中研究了袋熊腮腺形成唾液的机制,分别在中范围(最大流量的 30-40%)和最大流量下,使用离子转运和碳酸酐酶抑制剂刺激胆碱能。布美他尼(颈动脉血浆 0.005-0.1mmol l)逐渐将中范围流量减少 52 ± 3.4%(平均值 ± SEM)。同时,唾液 [Cl]降低,[Na]和 [HCO]增加,但 HCO 排泄未改变。高胆碱能刺激下的唾液流量为预布美他尼最大流量的 31 ± 1.1%。在中范围刺激期间,SITS(0.075mmol l)没有作用,而 0.75mmol l 刺激流体输出的短暂增加。较高的 SITS 浓度在最大刺激期间不会改变流量或电解质浓度。颈动脉血浆 [阿米洛利](0.05mmol l)导致流量立即下降 20-30%,然后在 25 分钟内逐渐恢复到高于预阿米洛利流量水平,尽管血浆 [阿米洛利]增加了十倍。同时,唾液 [Na]和 [Cl]上升到与血浆浓度相等,[K]下降 50%,表明在导管中阻断了腺泡 Na/H 交换器和腔道 Na 通道。增加的唾液渗透压导致了流量的恢复。最大胆碱能刺激下的唾液流量减少了 38-46%。流量的抑制被解释为阿米洛利和乙酰胆碱竞争进入毒蕈碱受体的结果。血浆 [乙酰唑胺](0.35-2.5mmol l)在中范围或最大流量范围内不会改变唾液流出量,而唾液 [Cl]增加,[HCO]减少,与由于碳酸酐酶抑制导致的阴离子交换减少一致。与布美他尼联合使用时,乙酰唑胺(1.5mmol l)使流量相对于布美他尼单独减少了 18-22%,从而证明了腺泡 HCO 合成支持了唾液形成的有限比例,并且一些 HCO 分泌与碳酸酐酶活性无关。